HCL Tech wins five-year contract with SAI Global
HCL Technologies announced that it has been appointed as the strategic IT partner to SAI Global. Under the terms of the five-year partner agreement, HCL Technologies will provide SAI Global with IT Managed Application Services and Projects .HCL Technologies was awarded the contract following a competitive tender evaluation to assist the company in delivering its newly integrated Global Sales and Marketing capability and the organisation’s Strategic Future Projects.
IndusInd Bank raises Rs752 crore via preferential issue
IndusInd Bank raised Rs752 crore from promoters by way of preferential issue at Rs857.20 (QIP issue was at price of Rs845 per share).With this issue, the bank has raised a total of Rs5081 crores in a month by issuing shares to QIP and preferential shares to promoters. The capital raised will help in strong balance sheet growth in the coming period.
Dr Reddy’s launches generic drug used for Parkinson’s disease
Dr Reddy’s Laboratories Ltd launched a generic drug in the US that is used for treatment of Parkinson’s disease. The drug is estimated to have clocked $48.3 million of sales for the most recent 12 months.
Cabinet clears policy on spectrum sharing
The Union Cabinet on Wednesday approved spectrum sharing guidelines, a move that would allow two operators to pool their spectrum in a given band within a circle for greater spectral efficiency. However, since the spectrum caps have neither been raised nor done away with, the norms would not enable two big operators with large spectrum holding, Bharti Airtel and MTNL, for instance, to share spectrum in a circle.
Aurobindo Pharma gains on strong Q1 performance
Revenue for the quarter grew by 14% YoY to Rs3320 crore which was driven by strong performance in US market. Revenue in US market grew by 28% YoY, led to a 16% YoY increase in formulation segment.
Operating margin during the quarter stood at 21.8% (in line with estimates). Hence operating profit for the quarter grew by 10% YoY to Rs724.7 crore. Earning for the quarter was Rs432 crore growth of 4% YoY, however it include forex exchange loss of Rs25.6 crore adjusting to that earnings for the quater grew by 10.6% YoY to Rs458 crore. We have currently Hold rating on the stock, will come out with detail update post the management concall.
CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market.